You can buy or sell WellCare and other stocks, options, ETFs, and crypto commission-free!
WellCare Health Plans, Inc. engages in the provision of government-sponsored managed care services through Medicaid, Medicare Advantage, and Medicare Prescription Drug Plans to families, children, seniors, and individuals with complex medical needs. It operates through the following segments: Medicaid Health Plans, Medicare Health Plans, and Medicare PDPs. Read More The Medicaid Health Plans segment includes plans for beneficiaries of TANF, SSI and ABD programs and other state-based programs that are not part of the Medicaid program, such as Children's Health Insurance Program and MLTC. The Medicare Health Plans segment provides a comprehensive array of Part C and Part D benefits to Medicare eligible persons, through the MA plans. The Medicare Prescription Drug Plans (PDP) segment serves as a plan sponsor offering stand-alone Medicare Part D PDP plans to Medicare-eligible beneficiaries through this segment. The company was founded in May 2002 and is headquartered in Tampa, FL.
St. Louis, Missouri
52 Week High
52 Week Low
Activist Third Point builds stake in health insurer Centene
Daniel Loeb's Third Point has built a stake in Centene as the health insurer works to complete its previously announced purchase of WellCare Health Plans.
Seeking AlphaMay 24
Centene perks up 3% on Third Point stake
Centene (CNC +2.6% ) is up on below-average volume (up 4% from the intraday low of $54.58) in apparent reaction to the news that Dan Loeb's Third Point Ventures owns at least a $300M stake in the managed care provider and, according to the Wall Street Journal, is urging the company to sell itself before swallowing WellCare Health Plans (WCG -0.3% ) for $15.3B. Activist investors, including Corvex and Sachem Head, in addition to Third Point, want management to consider potential buyout offers before consumm...
Seeking AlphaMay 23
Centene and WellCare file joint proxy for special meetings on merger
Centene (NYSE:CNC) and WellCare Health Plans (NYSE:WCG) have filed a prospectus and joint proxy statement ahead of their concurrent special shareholders meetings on June 24 during which investors will vote on the previously announced merger.
Expected Jul 30, Pre-Market